Article
Tumor Cell Spatial Organization Directs EGFR/RAS/RAF Pathway Primary Therapy Resistance…
medRxiv · 2025 · Nakagawa, R.; Beardsley, A.; Durney, S.; Hayward, M.-K.; Subramanyam, V.; Meyer, N. P.; Wismer, H.; Goodarzi, H.; Weaver, V. M.; Van de Mark, D.; Goga, A.
Key facts
| Title | Tumor Cell Spatial Organization Directs EGFR/RAS/RAF Pathway Primary Therapy Resistance through YAP Signaling |
|---|---|
| First author | Nakagawa, R.; Beardsley, A.; Durney, S.; Hayward, M.-K.; Subramanyam, V.; Meyer, N. P.; Wismer, H.; Goodarzi, H.; Weaver, V. M.; Van de Mark, D.; Goga, A. |
| Journal | medRxiv |
| Published | Jan 1, 2025 |
| DOI | 10.1101/2024.09.26.615226 |
| Devices mentioned | K040782, K213341 |
| Product codes mentioned | JAK, KGN, JJH, NPM |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1